文章名稱引用次數

• Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee110
• Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)19
• Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations*16
• Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?13
• Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis12
• Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study(#)12
• Polymorph-specific distribution of binding sites determines thioflavin-T fluorescence intensity in -synuclein fibrils11
• Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality11
• Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience10
• Seven factors predict a delayed diagnosis of cardiac amyloidosis9